Quality compass '99: slow, but steady improvements.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D006801:Humans; D008329:Managed Care Programs / Q000592:standards* / Q000706:statistics & numerical data; D009203:Myocardial Infarction / Q000188:drug therapy; D017063:Outcome Assessment, Health Care; D011785:Quality Assurance, Health Care; D012308:Risk Management; D012923:Social Class; D014481:United States
D000319:Adrenergic beta-Antagonists